Real World Experience of Second-Line Treatment Strategies after Palbociclib and Letrozole: Overall Survival in Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.

Ji-Yeon Kim,Junghoon Shin,Jin Seok Ahn,Yeon Hee Park,Young-Hyuck Im

Cancers（2023）

引用 0|浏览1

暂无评分

摘要

We suggested the second line treatment strategy was important to improve prognosis in patients with HR+/HER2- MBC, especially given the recent standardization of first-line treatment and the many available second-line options.

查看译文

关键词

second line treatment, palbociclib with letrozole, hormone receptor positive, HER-2 negative, metastatic breast cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要